Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06725108 · ClinicalTrials.gov registry record
Hemodynamic ABI Monitor
A clinical trial of Intracerebral Hemorrhage and Traumatic Brain Injury (TBI), sponsored by University of Chicago.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06725108: Recruiting study of Intracerebral Hemorrhage and Traumatic Brain Injury (TBI), sponsored by University of Chicago.
NCT06725108 is a study of Intracerebral Hemorrhage and Traumatic Brain Injury (TBI) that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 50 participants, below the 1,104-participant average among 31 other Intracerebral Hemorrhage trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06725108, a study of Intracerebral Hemorrhage and Traumatic Brain Injury (TBI), is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to explore the relationship of heart function with the course and outcomes after traumatic brain injuries and nontraumatic intracerebral hemorrhage. The goal is to explore association between routinely collected hemodynamic and brain monitoring data. Participants already taking intervention A as part of their regular medical care and the investigators will follow up with participants 6 months after discharging the hospital.
Primary Outcome
Primary endpoints are functional outcomes and quality of life at 180 days after hospital discharge. The follow-up functional status and quality of life measures will be done by telephone, in-person at their regularly scheduled follow-up appointment, or by email, for less than 30 minutes using validated instruments and/or using a web-based REDCap survey. However, these surveys can also be completed during the subject's 180-day follow up visit with their doctor or a telephone follow-up. The follow
Conditions Studied
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-12-06 |
| Est. Completion | 2026-12-06 |
What NCT06725108 shows while recruiting
NCT06725108 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,104-participant average among 31 other Intracerebral Hemorrhage trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Intracerebral Hemorrhage appearing as the primary indexed condition, and to 0 interventions.
NCT06725108 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06725108 about?
NCT06725108 is a clinical study titled "Hemodynamic ABI Monitor". The goal of this observational study is to explore the relationship of heart function with the course and outcomes after traumatic brain injuries and nontraumatic intracerebral hemorrhage. The goal is to explore association between routinely collected hemodynamic and brain monitoring data. Particip...
What is the current status of trial NCT06725108?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2024-12-06. Estimated completion is 2026-12-06.
What conditions does trial NCT06725108 study?
This clinical trial studies the following conditions: Intracerebral Hemorrhage, Traumatic Brain Injury (TBI).
Who is sponsoring clinical trial NCT06725108?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06725108 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracerebral Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06725108's enrollment target sits among peer trials
50 27th of 31 higher than 3 of 31 other Intracerebral Hemorrhage trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intracerebral Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
RECRUITING · Phase 3
-
Transitions of Care for Stroke Patients
RECRUITING
-
International Care Bundle Evaluation in Cerebral Hemorrhage Research
RECRUITING · Phase 4
-
ROSE-Longitudinal Assessment With Neuroimaging
RECRUITING
-
Optical Coherence Tomography Angiography in Neurological Disease
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI